References
- Kalantzis N, Gabriel P, Mouzas J, et al Acute amiodarone-induced hepatitis. Hepatogastroenterology. 1991;38:71-4.
- Giannatasio F, Salvio A, Varriale M, et al Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicity. Ann Ital Med Int. 2002;17:180-4.
- MacFadyen RJ, Palmer TJ, Hisamuddin K. Rapidly fatal acute amiodarone hepatitis occurring in the context of multiple organ failure. Int J Cardiol. 2003:91;245-7.
- Gayam V, Khalid M, Dahal S, et al Fatal Acute Liver Failure With Intravenous Amiodarone: A Case Report and Literature Review. Gastroenterology Res. 2018;11:62-3.
- Gluck N, Fried M, Porat R. Acute Isr Med Assoc J. 2011;13:748-052.
- Li JG, Yang TC, Yu DM, Ren TH. Fatal acute liver failure after intravenous amiodarone administration. J Formos Med Assoc. 2015;114:294-6.
- Verhovez A, Elia F, Riva A, Ferrari G, Aprà A. Acute liver injury after intravenous amiodarone: a case report. Am J Emerg Med. 2011;29:843.e5-6.
- Fromenty B, Fisch C, Labbe G, et al Amiodarone inhibits the mitochondrial beta-oxidation of faty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther. 1990;255:1371-6.
- Lewis JH, Mullick F, Ishak KG, et al Histopathologic analysis of suspected amiodarone toxicity. Human Pathol. 1990;21:59-67.
- Rätz Bravo AE, Drewe J, Schlienger RG, et al Hepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literature. Critical Care Med. 2005;33:128-34; discussion 245-6.
- Tsuda T, Tada H, Tanaka Y, et al Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports. J Med Case Rep. 2018;12:95.
- Chan AL, Hsieh HJ, Hsieh YA, Lin SJ. Fatal amiodarone-induced hepatotoxicity: A case report and literature review. Int J Clin Pharmacol Ther. 2008;46:96-101.
- Hashmi A, Keswani NR, Kim S, Graham DY. Hepatic Dysfunction in Patients Receiving Intravenous Amiodarone. South Med J. 2016;109:83-6.
- Diab OA, Kamel J, Abd-Elhamid AA. Predictors of intravenous amiodarone induced liver injury. Egypt Heart J. 2017;69:45-54.
- Chen CC, Wu CC. Acute Hepatotoxicity of Intravenous Amiodarone: Case Report and Review of the Literature. Am J Ther. 2016;23, e260-3.
- Hoofnagle JH, Björnsson ES. Drug-Induced Liver Injury - Types and Phenotypes. N Engl J Med. 2019;381:264-73.
- Begriche K, Massart J, Robin MA, Borgne-Sanchez A, Fromenty B. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol. 2011;54:773-94.
- Spaniol M, Bracher R, Ha HR, Follath F, Krähenbühl S. Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria. J Hepatol. 2001;35:628-36.
- Fromenty B, Fisch C, Berson A, et al Dual efect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling efect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther. 1990;255:1377-84.
- Kennedy JA, Unger SA, Horowitz JD. Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone. Biochem Pharmacol. 199;52:273-80.
- Felser A, Blum K, Lindinger PW, Bouitbir J, Krähenbühl S. Mechanisms of hepatocellular toxicity associated with dronedarone--a comparison to amiodarone. Toxicol Sci. 2013;131:480-90.
- Massart J, Begriche K, Buron N, et al Drug-induced inhibition of mitochondrial faty acid oxidation and steatosis. Curr Pathobiol Rep. 2013;1:147-57.
- Lheureux PE, Hantson P. Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol (Phila). 2009;47:101-11.
- Begriche K, Massart J, Robin MA, et al Mitochondrial adaptations and dysfunctions in nonalcoholic faty liver disease. Hepatology. 2013;58:1497-507.
- Massart J, Begriche K, Moreau C, et al Role of nonalcoholic faty liver disease as risk factor for drug-induced hepatotoxicity. J Clin Transl Res. 2017;3(Suppl 1):212-32.
- Matar W, Juliar B, Gradus-Pizlo I, et al Amiodarone hepatotoxicity in the context of the metabolic syndrome and right-sided heart failure. J Gastrointestin Liver Dis. 2009;18:419-23.